The 3‑month outperformance (+8.8% vs -0.7% S&P) is the most striking recent signal, implying that TALO’s fundamentals—such as its low‑cost production profile and recent asset acquisitions—are resonating with investors even when broader equities are under pressure.
The long‑term annualized return of only -0.6% over five years highlights limited upside; if crude prices stay below $70/bbl or capital expenditures rise sharply, the stock could underperform the market by an additional 5–7% annually, eroding its relative edge.
Despite overall strong institutional presence, the slight decline of -0.08% in institutional ownership hints at a subtle reallocation risk; if larger funds begin to trim exposure, it could amplify price swings given the stock's already high 47.1% volatility.
The most notable growth signal is the positive three‑year CAGR of 2.5%, which demonstrates that Talos has been able to grow revenue on a compounding basis even after accounting for cyclical downturns—an indication that its acquisition strategy and service diversification may provide a foundation for future upside if market conditions improve.
The deepening net loss margin of -27.9% poses a material risk: if operating cash flow fails to improve, the company may need to raise additional capital at unfavorable terms, which could dilute existing shareholders and constrain future growth initiatives.
Even after a 13-percentage‑point margin contraction, the equity multiplier’s increase magnifies losses, turning an otherwise extraordinary ROE into a negative figure—demonstrating that leverage is currently a liability rather than a lever for growth.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | -22.9 | -27.9 | 0.32 | 2.56 | -46.3 | -2.2 | -8.9 |
| 2024 | -2.8 | -3.9 | 0.32 | 2.24 | 3.3 | 3.2 | -1.2 |
| 2023 | 8.7 | 12.8 | 0.30 | 2.23 | 5.4 | 5.0 | 3.9 |
| 2022 | 32.8 | 23.1 | 0.54 | 2.62 | 30.2 | 30.0 | 12.5 |
| 2021 | -24.1 | -14.7 | 0.45 | 3.64 | 17.4 | 17.3 | -6.6 |
| 2020 | -50.2 | -80.8 | 0.20 | 3.06 | -17.8 | -17.7 | -16.4 |
| 2019 | 5.4 | 6.5 | 0.35 | 2.40 | 9.8 | 9.6 | 2.3 |
| 2018 | 22.0 | 24.9 | 0.36 | 2.46 | 12.1 | 12.1 | 8.9 |
| 2017 | 116.2 | -15.3 | 0.33 | -22.91 | 5.0 | 4.9 | -5.1 |
| 2016 | -2978.6 | -83.3 | 0.21 | 173.53 | -8.0 | -7.9 | -17.2 |
| 2015 | 1625.3 | -208.8 | 0.22 | -35.44 | -63.1 | -62.2 | -45.9 |
The -46.3% ROIC translates to a $1.5 billion shortfall in value creation on the current capital base; continued negative returns could trigger covenant breaches and force asset sales, eroding future growth prospects.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 1138 | 0 | 66 | 7 | 20 | 47 |
| 2024 | 1145 | 0 | 75 | 978 | 27 | 48 |
| 2023 | 1206 | 0 | 70 | 1014 | 29 | 40 |
| 2022 | 676 | 0 | 47 | 591 | 64 | -18 |
| 2021 | 811 | 0 | 64 | 707 | 46 | 18 |
| 2020 | 1796 | 0 | 111 | 1624 | 63 | 48 |
| 2019 | 1041 | 0 | 53 | 901 | 44 | 8 |
| 2018 | 1016 | 97 | 63 | 840 | 43 | 117 |
| 2017 | 1102 | 1 | 79 | 970 | 99 | -19 |
| 2016 | 1771 | 2 | 95 | 1524 | 102 | -5 |
| 2015 | 1662 | 1 | 111 | 1463 | 78 | 34 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $5552M | $3384M | $2168M | $1242M | $879M | $363M | $841M | $645M |
| 2024 | $6192M | $3432M | $2760M | $1241M | $1133M | $108M | $659M | $723M |
| 2023 | $4816M | $2661M | $2155M | $1196M | $1162M | $34M | $422M | $579M |
| 2022 | $3059M | $1893M | $1166M | $602M | $558M | $44M | $368M | $607M |
| 2021 | $2767M | $2006M | $761M | $981M | $911M | $70M | $340M | $601M |
| 2020 | $2835M | $1908M | $927M | $1006M | $972M | $34M | $247M | $448M |
| 2019 | $2589M | $1511M | $1078M | $752M | $665M | $87M | $294M | $370M |
| 2018 | $2480M | $1472M | $1007M | $655M | $515M | $140M | $417M | $380M |
| 2017 | $1239M | $1293M | $-54M | $698M | $665M | $32M | $145M | $323M |
| 2016 | $1212M | $1205M | $7M | $701M | $669M | $32M | $155M | $191M |
| 2015 | $1410M | $1450M | $-40M | $1061M | $1050M | $11M | $150M | $159M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $936M | $-547M | $-165M | $-482M | $454M | $-119M | |
| 2024 | $963M | $-1320M | $436M | $-509M | $454M | $-45M | |
| 2023 | $519M | $-513M | $85M | $-561M | $-42M | $-48M | |
| 2022 | $710M | $-312M | $-423M | $-323M | $387M | $-5M | |
| 2021 | $411M | $-294M | $-82M | $-293M | $118M | $-3M | |
| 2020 | $302M | $-679M | $324M | $-363M | $-61M | $-1M | |
| 2019 | $394M | $-496M | $48M | $-463M | $-70M | $-0M | |
| 2018 | $263M | $37M | $-193M | $-241M | $23M | ||
| 2017 | $176M | $-158M | $-18M | $-155M | $21M | ||
| 2016 | $116M | $-199M | $92M | $-113M | $3M | $-2M | |
| 2015 | $138M | $-285M | $108M | $-246M | $-107M | $-2M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net